Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Olympus Corp ADR (OP: OCPNY )

N/A UNCHANGED
Last Price Updated: 2:34 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 18.00
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
From Olympus
Via JCN Newswire
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
From Olympus
Via JCN Newswire

Performance

More News

Read More
Olympus Names Dr. John de Csepel as Chief Medical Officer
From Olympus
Via JCN Newswire
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
From Olympus
Via JCN Newswire
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision
From Olympus
Via JCN Newswire
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer
From Olympus
Via JCN Newswire
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
From Olympus
Via JCN Newswire
Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years
From Olympus
Via JCN Newswire
Olympus Announces Launch of Olympus Asia Pacific Innovation Program
From Olympus
Via JCN Newswire
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
Via JCN Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.